Xilis
Durham, United States· Est.
Xilis develops precision oncology platforms using patient-derived organoid models for drug testing and personalized medicine.
Private Company
Total funding raised: $73M
About
Xilis develops precision oncology platforms using patient-derived organoid models for drug testing and personalized medicine.
DiagnosticsDrug Delivery
Funding History
2Total raised:$73M
Series A$70M
Seed$3M